Cross Cancer Institute
64
4
5
39
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.3%
13 terminated/withdrawn out of 64 trials
75.0%
-11.5% vs industry average
2%
1 trials in Phase 3/4
0%
0 of 39 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (64)
Cycling-Based Aerobic Exercise Intervention for Individuals With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Role: collaborator
Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management
Role: collaborator
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
Role: collaborator
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
Role: collaborator
Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study
Role: collaborator
Unilateral Neck Radiotherapy in Head and Neck Cancer
Role: collaborator
Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions
Role: collaborator
Bladder Cancer and ExeRcise Training During IntraVesical ThErapy
Role: collaborator
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
Role: collaborator
p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)
Role: collaborator
Trial of Hypofractionated Radiation Therapy for Glioblastoma
Role: collaborator
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
Role: collaborator
Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors
Role: collaborator
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
Role: collaborator
A Tailored Exercise Oncology Program for Neuro-Oncology Patients
Role: collaborator
Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
Role: collaborator
Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
Role: collaborator
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Role: collaborator
Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects
Role: collaborator
Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer
Role: collaborator